期刊文献+

窄谱强脉冲光治疗痤疮红斑的疗效观察

Effect of narrow spectrum intense pulsed light on acne erythema
原文传递
导出
摘要 目的观察窄谱强脉冲光(dye pulsed light,DPL;波长500 nm)治疗面部痤疮红斑的临床效果。方法自2022年1—12月,济宁市第一人民医院医学美容科收治74例面部轻中度痤疮红斑患者,均采用DPL(波长500 nm)治疗,根据患者的病情,以及治疗后的反应,采取个性化制定1~3次的治疗方案。所有疗程结束后1个月,对患者治疗前后进行临床红斑评定量表(clinician's erythema assessment,CEA)评分,比较患者治疗前后CEA评分。结果74例患者中,治疗1次19例;治疗2次29例;治疗3次26例。采用DPL治疗轻中度痤疮红斑的有效率为89.2%(66/74),治疗前CEA权重评分为(2.69±0.55)分,治疗后降低为(1.18±0.94)分,治疗前后比较,差异有统计学意义(Z=-7.401,P<0.05)。结论DPL治疗面部痤疮红斑,安全性较高,效果较好,无严重不良反应,值得临床推广使用。 Objective To observe the effect of narrow spectrum intense pulsed light(DPL 500 nm)on acne erythema.Methods From January 2022 to December 2022,74 patients with facial acne erythema admitted were treated with DPL.According to the patient's condition and the reaction after treatment,a personalized treatment plan of 1 to 3 times will be formulated.One month after the end of all treatment courses,the clinician's erythema assessment(CEA)scores were performed before and after treatment,and the CEA scores of the patients before and after treatment were compared.Results Among the 74 patients,19 were treated once;29 cases were treated twice;26cases were treated 3 times.The effective rate of treatment with 500 nm intense pulsed light was 89.2%(66/74),CEA weight score was(2.69±0.55)before treatment,CEA weight score was reduced to(1.18±0.94)after treatment,and the difference was statistically significant before and after treatment(Z=-7.401,P<0.05).Conclusion Intense pulsed light is safe and effective in the treatment of facial acne erythema,with no obvious adverse reactions.It is worth popularizing.
作者 程玉 韩景健 张帆 宋朋朋 马会强 高凤林 CHENG Yu;HAN Jingjian;ZHANG Fan;SONG Pengpeng;MA Huiqiang;GAO Fenglin(Department of Medical Aesthetics,Jining First People's Hospital,Jining 272000,China)
出处 《中国美容整形外科杂志》 CAS 2024年第10期583-585,604,共4页 Chinese Journal of Aesthetic and Plastic Surgery
关键词 强脉冲光 痤疮红斑 窄谱 Intense pulsed light Acne rosacea Narrow spectrum
  • 相关文献

参考文献11

二级参考文献76

  • 1Maibach HI.The cosmetic intolerance syndrome[J].Ear Nose Throat, 1987,66(1):29-33.
  • 2Maibach HI,Engasser P.Management of cosmetic intolerance syndrome[J].Clin Dermatol, 1988,6(3): 102-107.
  • 3Farage MA,Katsarou A,Maibach HI. Sensory, clinical and physiological factors in sensitive skin:a review[J].Contact Dermatitis,2006,55(1): 1-14.
  • 4Willis CM,Shaw S,De Lacharriere O,et al.Sensitive skin: an epidemiological study[J].Br J Dermatol,2001,145(2):258- 263.
  • 5Berardesca E,Farage M,Maibach H.Sensitive skin:an overview[J].Int J Cosmet Sci,2013,35:2-8.
  • 6Seidenari S,Francomano M,Mantovani L.Baseline biophysical parameters in subjects with sensitive skin[J]. Contact Dermatitis, 1998,38(6):311-315.
  • 7Robinson MK.Population differences in acute skin irritation responses[J].Contact Dermatitis,2002,46 (2):86-93.
  • 8Stander S,Schneider SW, Weishaupt C,et al.Putativeneuronal mechanisms of sensitive skin[J].Exp Dermatol, 2009,18(5):417-423.
  • 9Reilly DM,Parslew R, Sharpe GR,et al.Inflammatory mediators in normal, sensitive and diseased skin types[J]. Acta Derm Venereol,2000,80(3): 171-174.
  • 10Yoon TY, Kim HJ,Kim MK.Pimecrolimus-induced rosacea- .like demodicidosis[J].Int J Dermatol,2007,46(10):l103- 1105.

共引文献118

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部